For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval. According to the National Cancer ...

One in 6 patients with colorectal cancer have an inherited cancer-related gene mutation which likely predisposed them to the disease, according to a Mayo Clinic study. About 16 percent of the 361 ...

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has studied alterations in the KRAS gene in colorectal cancer by combining genomic ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene — a gene that can cause cancer — that may play an important role in colon cancer. Researchers also showed how this ...

Implications for colorectal cancer patients considering immunotherapy Although rare, patients with CRC benefit from identifying the exact type of POLE mutation they might carry. Those with LOP POLE ...

Bottom line: Colorectal cancer and pancreatic ductal adenocarcinoma that harbored the KRAS G12C mutation often carried other genetic alterations that can be associated with resistance to KRAS G12C ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...